Post-marketing surveillance study of the safety of dexamethasone intravitreal implant in patients with retinal vein occlusion or noninfectious posterior segment uveitis

Post-marketing surveillance study of the safety of dexamethasone intravitreal implant in patients with retinal vein occlusion or noninfectious posterior segment uveitis

Adnan Tufail,1 Sue Lightman,1 Ahmed Kamal,2 Uwe Pleyer,3 Nuria María Gajate Paniagua,4 Corrine Dot,5,6 Xiao-Yan Li,7 Jenny Jiao,7 Jean Lou,7 Yehia Hashad7 For the CONSTANCE Study Group 1Moorfields Eye Hospital, London, UK; 2Aintree University Hospital, Liverpool, UK; 3Un...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tufail A, Lightman S, Kamal A, Pleyer U, Gajate Paniagua NM, Dot C, Li XY, Jiao J, Lou J, Hashad Y
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
corticosteroid
dexamethasone
drug delivery device
retinal vein occlusion
safety profile
uveitis
Ophthalmology
RE1-994
Acceso en línea:https://doaj.org/article/49c25c24a1c04ef4b9126cabaafb125b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/49c25c24a1c04ef4b9126cabaafb125b

Ejemplares similares